Eli Lilly has announced a $3bn expansion to the US manufacturing facility that it acquired from Nexus Pharmaceuticals earlier ...

Johnson & Johnson (J&J) has shared positive data from a late-stage study of its subcutaneous CD38-directed antibody Darzalex ...

Sanofi has presented promising results from a phase 3 study of its investigational oral Bruton’s tyrosine kinase (BTK) ...

Of the patients in the poze-cemdi group, 93% achieved LDH normalisation across study visits on average, compared to 65% of ...

GSK and Rgenta Therapeutics have partnered to develop RNA-targeting small molecule splice modulators for disease areas ...

From animation and gamification, to events, influencers, opinion leaders, and chatbots; there are tools and tactics which can ...

The National Institute for Health and Care Excellence (NICE) has recommended Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD). The drug has been recommended ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Roche has shared new long-term results from a phase 3 study of its anti-CD79b antibody-drug conjugate Polivy (polatuzumab ...

Novartis will be gaining exclusive global rights to PTC Therapeutics’ mid-stage Huntington’s disease (HD) programme in a deal ...

Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The ...

Great Place To Work® and Fortune have ranked CMI Media Group and Compas as number 10 on the 2024 Fortune Best Workplaces in ...